The social stigma surrounding the pharmaceutical industry has gotten pretty bad lately. The business of saving lives is now rated positively by only 32% of the public, tucked neatly between oil and banking in consumer confidence polls – down eight places since 1996. Without dwelling too much into the reasons for pharma’s tumbling social status, one can sense an undeniable skepticism surrounding the intentions of the industry, and, most frighteningly, the effectiveness of its drugs.
Ambien is one of a number of Controlled Schedule 4 agents designed as sedative hypnotics. Like other sedative hypnotics they are usually effective for about two weeks, largely to relieve persisting insomnia. These agents, especially Ambien, are linked to sleep-driving, eating, and even sex.
A new battle has been waged on Capitol Hill surrounding the much-debated legalization of medical marijuana. As research continues solidifying the positive effects of using cannabis to treat certain clinical symptoms, some research is focusing on the possible effects it may have on treating Post Traumatic Stress Disorder (PTSD).
Before I actually get started on this article, I would like to immediately answer the question I posed in the title: no. Psychoactive drugs are alive and well. But they might not be for long.